{
  "query": "type adverse time related",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT02728986",
          "briefTitle": "Cost Evaluation of Venous Leg Ulcers Management"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-07-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Varicose Ulcer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 176,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06779773",
          "briefTitle": "A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-01-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Geographic Atrophy", "Macular Degeneration"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05653622",
          "briefTitle": "Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-07-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Glioblastoma Multiforme, Adult"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 75,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02260531",
          "briefTitle": "Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-03-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Breast Cancer", "Brain Tumor - Metastatic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02115737",
          "briefTitle": "Group Treatment for Adolescents With Depression"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-12"
          },
          "completionDateStruct": {
            "date": "2014-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Depression"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04233775",
          "briefTitle": "Altered Cerebral Growth and Development in Infants With Congenital Heart Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Neurodevelopmental Disorders", "Congenital Heart Disease", "Brain Injuries", "Fetal Growth Retardation"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "0 Days",
          "maximumAge": "6 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05567601",
          "briefTitle": "Doxil/Caelyx BE Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Ovarian Cancer", "AIDS-related Kaposi Sarcoma", "Multiple Myeloma", "Metastatic Breast Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02839681",
          "briefTitle": "Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-07-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-07-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lung Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05176925",
          "briefTitle": "Tislelizumab Combined With Sitravatinib as Consolidation Treatment Following Concurrent Chemoradiation in Patients With Locally Advanced, Unresectable NSCLC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non-small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06820268",
          "briefTitle": "A Study of XS-04 in Patients with Relapsed or Refractory Hematologic Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-03-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["B-cell Lymphoma", "Acute Myeloid Leukemia", "Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 168,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03590210",
          "briefTitle": "Combined Treatment With Nivolumab and Trabectedin in Patients With Metastatic or Inoperable Soft Tissue Sarcomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-06-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Adult Soft Tissue Sarcoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 92,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04806659",
          "briefTitle": "A Phase 1 Study of SH1573 Capsules in Subjects With Refractory or Relapsed Acute Myelogenous Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myelogenous Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 41,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01005680",
          "briefTitle": "A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-11"
          },
          "completionDateStruct": {
            "date": "2012-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non Small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 256,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06330480",
          "briefTitle": "Check@Home: General Population Screening for Early Detection of Atrial Fibrillation and Chronic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-11-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Atrial Fibrillation", "Chronic Kidney Diseases", "Diabetes Mellitus, Type 2"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 320000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04905810",
          "briefTitle": "Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Recurrent Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06507813",
          "briefTitle": "Safety and Efficacy of ADC189 in Children 2-11 Years Old With Influenza"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-04-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Influenza Type A", "Influenza Type B"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 190,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "11 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04796688",
          "briefTitle": "Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-03-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Chronic Lymphoblastic Leukemia", "B-cell Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 27,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "78 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05557903",
          "briefTitle": "Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoma, Non-Hodgkin", "Lymphoma, T-Cell"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 71,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03783442",
          "briefTitle": "A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-12-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Esophageal Squamous Cell Carcinoma (ESCC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 649,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01520870",
          "briefTitle": "Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-02"
          },
          "completionDateStruct": {
            "date": "2017-03-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Glioblastoma", "Brain Tumor, Recurrent"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 49,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06929169",
          "briefTitle": "Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Kidney Disease Requiring Hemodialysis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05756283",
          "briefTitle": "The PREHAAAB Trial: Multimodal Prehabilitation for Patients Awaiting Open Abdominal Aortic Aneurysm Repair"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-09",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Abdominal Aortic Aneurysm"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 152,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02392754",
          "briefTitle": "Home-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and Older"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-01-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Atrial Fibrillation", "Hypertension"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 856,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04873375",
          "briefTitle": "Cemiplimab for Secondary Angiosarcomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-10-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Secondary Angiosarcoma", "Locally Advanced Sarcoma", "Metastasis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05569512",
          "briefTitle": "Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-10-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Pediatric Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Months",
          "maximumAge": "39 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02944565",
          "briefTitle": "Daratumumab in Treating Patients With Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-07-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Plasma Cell Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03070132",
          "briefTitle": "802NP301 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-19",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-08-21",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Trigeminal Neuralgia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02642393",
          "briefTitle": "Study of Urate Elevation in Parkinson's Disease, Phase 3"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Parkinson's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 298,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03086993",
          "briefTitle": "Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Bile Duct Cancer", "Intrahepatic Cholangiocarcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 295,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02599493",
          "briefTitle": "EVRIOS : Comparative Evaluation of Low Versus High Doses of Rifampicin"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-01"
          },
          "completionDateStruct": {
            "date": "2020-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Osteoarticular Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 544,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03952637",
          "briefTitle": "A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-08-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-01-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Lysosomal Diseases", "Gangliosidosis", "GM1"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 54,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04660175",
          "briefTitle": "The Efficacy and Safety of Non-resistance Manual Therapy in Inpatients With Acute Neck Pain Caused by Traffic Accidents: a Randomised Controlled Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-07-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Whiplash Injury of Cervical Spine"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04128501",
          "briefTitle": "Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Bilineal Leukemia", "Acute Biphenotypic Leukemia", "Acute Myeloid Leukemia", "Mixed Phenotype Acute Leukemia", "T Acute Lymphoblastic Leukemia", "Therapy-Related Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 125,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03320330",
          "briefTitle": "Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Recurrent Malignant Solid Neoplasm", "Recurrent Osteosarcoma", "Refractory Malignant Solid Neoplasm", "Refractory Osteosarcoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 26,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Months",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02028507",
          "briefTitle": "Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-03-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-01-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 693,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01428492",
          "briefTitle": "Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-12"
          },
          "completionDateStruct": {
            "date": "2015-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 90,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01761292",
          "briefTitle": "A Study to Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-04"
          },
          "completionDateStruct": {
            "date": "2017-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Duchenne Muscular Dystrophy (DMD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "7 Years",
          "maximumAge": "11 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06826144",
          "briefTitle": "Chronic Remote Ischemic Conditioning in Small Infarctions Associated with Stent-assisted Coiling of Unruptured Intracranial Aneurysms"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-02-20",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Unruptured Intracranial Aneurysm", "Infarction Cerebral"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 84,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06491199",
          "briefTitle": "Home Assessment of Blood Pressure in PregnancY"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hypertensive Disorder of Pregnancy"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01514214",
          "briefTitle": "Winged Perimeter Versus Traditional Plastic Biliary Stent for Malignant Bile Duct Obstruction"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Malignant Tumor of Extrahepatic Bile Duct"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 58,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03126019",
          "briefTitle": "A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 126,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07092007",
          "briefTitle": "NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-06-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Intraepithelial Neoplasia", "Cervical Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03929107",
          "briefTitle": "Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T for Refractory/Relapsed B Cell Lymphoma."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-04-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "B Cell Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04003636",
          "briefTitle": "Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-09-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-04-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Biliary Tract Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1069,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07204834",
          "briefTitle": "A Physical Activity Program for People With Heart Failure"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Heart Failure"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01508364",
          "briefTitle": "Nexavar as First Targeted Therapy in Patients With Advanced Renal Cell Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-07"
          },
          "completionDateStruct": {
            "date": "2013-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Renal Cell"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01062399",
          "briefTitle": "Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-12"
          },
          "completionDateStruct": {
            "date": "2022-05-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Brain and Central Nervous System Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 279,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03113799",
          "briefTitle": "A Study Evaluate Aqueduct's Smart External Drain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-04-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-01-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hydrocephalus", "Hydrocephalus in Children", "Tumor, Brain"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 56,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "5 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05819463",
          "briefTitle": "Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 700,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01839487",
          "briefTitle": "PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-05-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-09-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Pancreatic Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 279,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04608487",
          "briefTitle": "Axi-cel in CNS Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2038-06-14",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoma", "Lymphoma Cns"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02622321",
          "briefTitle": "A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-11-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hemophilia A"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 113,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02181075",
          "briefTitle": "Targeted Chemotherapy Using Focused Ultrasound for Liver Tumours"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-07"
          },
          "completionDateStruct": {
            "date": "2017-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Liver Tumour"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03445065",
          "briefTitle": "A French Study to Evaluate the Usefulness of an Implantable Continuous Glucose Monitoring (CGM) Sensor to Improve Glycemic Control in Participants With Diabetes Mellitus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-02-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes Mellitus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 239,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03514407",
          "briefTitle": "A Study of INCB059872 in Relapsed or Refractory Ewing Sarcoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-06-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-06-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Relapsed Ewing Sarcoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05821192",
          "briefTitle": "Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Peripheral T-Cell Lymphoma, Not Otherwise Specified", "Angioimmunoblastic T-cell Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05061563",
          "briefTitle": "A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men", "Hot Flashes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04030598",
          "briefTitle": "A Study to Assess the Clinical Efficacy of Donidalorsen (Also Known as IONIS-PKK-LRx and ISIS 721744) in Participants With Hereditary Angioedema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-03-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hereditary Angioedema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05301764",
          "briefTitle": "A Study of LVGN6051 Combined with Anlotinib in Patient with Soft Tissue Sarcoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-10-19",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Soft Tissue Sarcoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 65,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03377699",
          "briefTitle": "Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-11-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetes", "Diabetes Mellitus, Type 1"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 225,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00390299",
          "briefTitle": "Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-10-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-11-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Anaplastic Astrocytoma", "Anaplastic Oligodendroglioma", "Mixed Glioma", "Recurrent Glioblastoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04923893",
          "briefTitle": "A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2036-09-22",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 743,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01847521",
          "briefTitle": "Effects of the Anti-inflammatory Flavonoid Luteolin on Behavior in Children With Autism Spectrum Disorders"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-12"
          },
          "completionDateStruct": {
            "date": "2013-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Autism Spectrum Disorders"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "4 Years",
          "maximumAge": "10 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00975806",
          "briefTitle": "Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2011-10-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Renal Cell Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06345001",
          "briefTitle": "A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hepatocellular Carcinoma (HCC)", "Solid Tumors"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04831567",
          "briefTitle": "Study of MIBG-I131 in Patients With Well Differentiated Neuroendocrine Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-05-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neuroendocrine Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07185412",
          "briefTitle": "Spanish Registry of Redo Procedures Following Pulmonary Vein Ablation by Pulsed Field Ablation Technology: RESET-PFA"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2030-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cardiac Arrhythmia", "Atrial Fibrillation", "Pulsed Field Ablation"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01177800",
          "briefTitle": "A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-02"
          },
          "completionDateStruct": {
            "date": "2010-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Psoriasis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 129,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06389292",
          "briefTitle": "A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-06-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-03-26",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 486,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04548271",
          "briefTitle": "Camrelizumab Combined With Apatinib in Patients With PD-1 Antagonists Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Nasopharyngeal Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02294734",
          "briefTitle": "An Efficacy Study of GSK2269557 Added to Standard Care in Subjects With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-04-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Disease, Chronic Obstructive"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 126,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05371132",
          "briefTitle": "Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Metastatic Malignant Solid Neoplasm", "Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05697614",
          "briefTitle": "The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Drug Resistant Epilepsy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01964430",
          "briefTitle": "Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the \"Apact\" Study)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-03-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Pancreatic Neoplasms", "Digestive System Neoplasms", "Neoplasms by Site", "Neoplasms", "Endocrine Gland Neoplasms", "Pancreatic Diseases", "Digestive System Diseases", "Endocrine System Diseases", "Gemcitabine", "Antimetabolites, Antineoplastic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 866,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01475734",
          "briefTitle": "Albiglutide Glucose Clamp Study in Subjects With Type 2 Diabetes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-12"
          },
          "completionDateStruct": {
            "date": "2012-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes Mellitus, Type 2"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04150471",
          "briefTitle": "Assess Long-term Feasibility of Reduced Dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Myelocytic Leukemia"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 79,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04152863",
          "briefTitle": "Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced/Metastatic Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 85,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05678621",
          "briefTitle": "Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Haematological Malignancy", "Hypogammaglobulinemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02872714",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "UC (Urothelial Cancer)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 263,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04409314",
          "briefTitle": "Hypoxia-Specific Imaging to Predict Outcomes of Chimeric Antigen Receptor T-cell Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-04-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Recurrent Aggressive Non-Hodgkin Lymphoma", "Recurrent Diffuse Large B-Cell Lymphoma", "Recurrent High Grade B-Cell Lymphoma", "Recurrent Malignant Neoplasm", "Recurrent Plasma Cell Myeloma", "Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma", "Refractory Aggressive Non-Hodgkin Lymphoma", "Refractory Diffuse Large B-Cell Lymphoma", "Refractory High Grade B-Cell Lymphoma", "Refractory Malignant Neoplasm", "Refractory Plasma Cell Myeloma", "Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04808882",
          "briefTitle": "ANTIcoagulation in Severe COVID-19 Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-04-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-03-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Severe COVID-19 Pneumonia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 353,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02626624",
          "briefTitle": "Safety and Efficacy of the CarboClear Pedicle Screw System"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Degenerative Disc Disease", "Spondylolisthesis, Grade 1"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 57,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years",
          "maximumAge": "72 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04241523",
          "briefTitle": "Efficacy and Safety of Lenvatinib as a Conversion Therapy for HCC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2022-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatocellular Carcinoma (HCC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00103662",
          "briefTitle": "Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-01"
          },
          "completionDateStruct": {
            "date": "2008-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 302,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "78 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02624388",
          "briefTitle": "Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-08"
          },
          "completionDateStruct": {
            "date": "2021-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoma", "Childhood Lymphoma", "Solid Tumor", "Childhood Solid Tumor", "Neuroblastoma", "Ewing Sarcoma", "Hodgkin Lymphoma", "Non-Hodgkin Lymphoma", "Rhabdomyosarcoma", "Soft Tissue Sarcoma", "Medulloblastoma", "Germ Cell Tumor", "Wilms Tumor", "Brain Neoplasms", "Medulloblastoma, Childhood", "Neuroectodermal Tumors, Primitive"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04575961",
          "briefTitle": "Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-03-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Ovarian Cancer", "Low Grade Serous Carcinoma", "Primary Peritoneal Carcinoma", "Fallopian Tube Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 33,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04930770",
          "briefTitle": "Study About the Response to the Administration of a Third Dose of mRNA-1273 Vaccine (COVID-19 Vaccine Moderna) in Renal Transplants With Immunological Failure Initial to Vaccination"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2022-03-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Covid19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01905683",
          "briefTitle": "Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-08"
          },
          "completionDateStruct": {
            "date": "2017-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lower Limb and Combined Lower Limb and Upper Limb Spasticity Due to Cerebral Palsy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 370,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04354441",
          "briefTitle": "Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2020-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID-19", "SARS-CoV-2", "Pregnant Women", "Hydroxychloroquine"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04925141",
          "briefTitle": "A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Myelogenous Leukemia - Chronic Phase"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02999854",
          "briefTitle": "Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-11-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Acute Lymphoblastic Leukemia", "Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 63,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04945356",
          "briefTitle": "Telerehabilitation During Pandemic Containment Measures of COVID19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Stroke"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00875056",
          "briefTitle": "Study of Vorinostat (MK-0683) With Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL), or Mantle Cell Lymphoma (MCL) Participants (MK-0683-103)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-04-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-02-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 56,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years",
          "maximumAge": "74 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02599402",
          "briefTitle": "Nivolumab Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Treatment for Patients With Advanced Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-02-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 533,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02989857",
          "briefTitle": "Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-05-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Cholangiocarcinoma", "Metastatic Cholangiocarcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 187,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03730012",
          "briefTitle": "A Study of ASP2215 (Gilteritinib) Combined With Atezolizumab in Patients With Relapsed or Treatment Refractory FMS-like Tyrosine Kinase (FLT3) Mutated Acute Myeloid Leukemia (AML)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-06-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia (AML)", "Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00673465",
          "briefTitle": "Effect of SCH 497079 on Metabolic Parameters and Influence of Race/Ethnic Origin on Therapeutic Response (Study P05338)(COMPLETED)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-04-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2008-12-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Type 2 Diabetes Mellitus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02234232",
          "briefTitle": "The Feasibility and Safety of an Intradialytic Exercise Program: DIALY-SIZE"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-07"
          },
          "completionDateStruct": {
            "date": "2014-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "End-stage Renal Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 31,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03470922",
          "briefTitle": "A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-12-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 714,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02898753",
          "briefTitle": "VAL-1221 Delivered Intravenously in Ambulatory and Ventilator-free Participants With Late-Onset Pompe Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-06-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-03-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pompe Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      }
    ],
    "protocolSection.1": [
      {
        "identificationModule": {
          "nctId": "NCT05770037",
          "briefTitle": "DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Haematological Malignancy", "Malignant Neoplasm", "Lymphoproliferative Disorders", "Neoplasms by Histologic Type", "Neoplasms by Site", "Cancer", "Anaplastic Large Cell Lymphoma", "Lymphoma", "Renal Cell Carcinoma", "Neuroblastoma", "Solid Tumour"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02987712",
          "briefTitle": "Management of Coagulopathy in Cirrhotic Patients Undergoing Invasive Procedures"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-12"
          },
          "completionDateStruct": {
            "date": "2018-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Liver Cirrhosis", "Coagulopathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05061030",
          "briefTitle": "Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Type1diabetes"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 66,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "7 Years",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01348828",
          "briefTitle": "Feasibility and Safety Study of the Endologix Fenestrated Stent Graft System"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-10-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-03-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Abdominal Aortic Aneurysm"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 49,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05693467",
          "briefTitle": "Preemptive Co-infiltration of Dexamethasone Palmitate With Ropivacaine for Postoperative Pain in Major Spinal Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pain, Postoperative"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 124,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "64 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04387500",
          "briefTitle": "Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-01-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Carcinoma, Renal Cell", "Fumarate Hydratase Deficiency", "Immunotherapy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 41,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03797144",
          "briefTitle": "Fenestrated Screw Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-04-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Degenerative Spinal Disease", "Deformity of Spine"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 27,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "22 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07074444",
          "briefTitle": "Treatment of Clonorchiasis in Guangxi With Albendazole, Tribendimidine, and Praziquantel"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Clonorchiasis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 318,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04478695",
          "briefTitle": "Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Relapsed or Refractory Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01137695",
          "briefTitle": "Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-05"
          },
          "completionDateStruct": {
            "date": "2012-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Type 2 Diabetes Mellitus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06970275",
          "briefTitle": "To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-11-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-01-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostate Cancers", "Breast Cancer", "Head and Neck Cancer", "Cancer"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 850,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00396201",
          "briefTitle": "AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-11"
          },
          "completionDateStruct": {
            "date": "2008-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hodgkin's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 22,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06361719",
          "briefTitle": "Efficacy of Two HMOs in Chinese Infants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy Infants"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 262,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "3 Days",
          "maximumAge": "14 Days"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00823719",
          "briefTitle": "Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-05"
          },
          "completionDateStruct": {
            "date": "2011-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Large-Cell, Diffuse"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 61,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01678430",
          "briefTitle": "A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-12"
          },
          "completionDateStruct": {
            "date": "2017-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Lymphocytic Leukaemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 670,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06219707",
          "briefTitle": "Electro-acupuncture for Irritable Bowel Syndrome With Constipation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-09-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Irritable Bowel Syndrome With Constipation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "21 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03221634",
          "briefTitle": "Efficacy and Safety Study of Pembrolizumab (MK-3475) in Combination With Daratumumab in Participants With Relapsed Refractory Multiple Myeloma (MK-3475-668/KEYNOTE-668)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-08-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2021-06-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03734198",
          "briefTitle": "Evaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 Dysfunction"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-12-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-19",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Relapsed or Refractory Chronic Lymphocytic Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 29,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04331587",
          "briefTitle": "Thin and Ultrathin Bronchoscopy With Transbronchial Needle Aspiration and Radial Probe Endobronchial Ultrasound for Peripheral Pulmonary Lesions"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-04-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Peripheral Pulmonary Nodules"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01140451",
          "briefTitle": "Extension Study of Ataluren (PTC124) in Cystic Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-08-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-12-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 191,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03217253",
          "briefTitle": "Tazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver Dysfunction"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-09-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma", "Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma", "Metastatic Malignant Solid Neoplasm", "Stage III Hepatocellular Carcinoma AJCC v7", "Stage IIIA Hepatocellular Carcinoma AJCC v7", "Stage IIIB Hepatocellular Carcinoma AJCC v7", "Stage IIIC Hepatocellular Carcinoma AJCC v7", "Stage IV Hepatocellular Carcinoma AJCC v7", "Stage IVA Hepatocellular Carcinoma AJCC v7", "Stage IVB Hepatocellular Carcinoma AJCC v7", "Unresectable Solid Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05890872",
          "briefTitle": "Aliya™ Pulsed Electric Fields (PEF) for Advanced Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-09-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-08-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lung Neoplasm Malignant"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "22 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07093801",
          "briefTitle": "Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-03-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Castration Resistant Prostate Cancer"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00057330",
          "briefTitle": "HerpeVac Trial for Young Women"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-01-14"
          },
          "completionDateStruct": {
            "date": "2009-08-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Simplex Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 8323,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06462365",
          "briefTitle": "Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-04-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hematologic Malignancy", "GvHD", "GVHD,Acute", "GVHD, Chronic", "Hematopoietic Stem Cell Transplant", "Acute Lymphoblastic Leukemia, Adult B-Cell", "Acute Lymphoblastic Leukemia, Adult T-Cell", "Acute Myeloid Leukemia in Remission", "Myelodysplastic Syndromes", "Chronic Myelomonocytic Leukemia, in Remission", "Cancer Remission"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02446600",
          "briefTitle": "Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-08-23",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Fallopian Tube Clear Cell Adenocarcinoma", "Fallopian Tube Transitional Cell Carcinoma", "Fallopian Tube Undifferentiated Carcinoma", "Ovarian Clear Cell Adenocarcinoma", "Ovarian Endometrioid Tumor", "Ovarian Seromucinous Carcinoma", "Ovarian Serous Tumor", "Ovarian Transitional Cell Carcinoma", "Ovarian Undifferentiated Carcinoma", "Recurrent Fallopian Tube Carcinoma", "Recurrent Ovarian Carcinoma", "Recurrent Ovarian Endometrioid Adenocarcinoma", "Recurrent Primary Peritoneal Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 579,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01610336",
          "briefTitle": "A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-04-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-05-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non-small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 161,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05694871",
          "briefTitle": "Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-05-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Dedifferentiated Liposarcoma", "Locally Advanced Dedifferentiated Liposarcoma", "Metastatic Dedifferentiated Liposarcoma", "Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC V8", "Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC V8", "Unresectable Dedifferentiated Liposarcoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 77,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04300556",
          "briefTitle": "A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-08-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Solid Tumor"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 182,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06702553",
          "briefTitle": "Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Nitric Oxide", "Cardiac Surgery", "Cardiopulmonary Bypass", "Adult Patients Undergoing Cardiovascular Surgery With Cardiopulmonary Bypass"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3650,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02359565",
          "briefTitle": "Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-06-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-21",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Constitutional Mismatch Repair Deficiency Syndrome", "Lynch Syndrome", "Malignant Glioma", "Recurrent Brain Neoplasm", "Recurrent Childhood Ependymoma", "Recurrent Diffuse Intrinsic Pontine Glioma", "Recurrent Medulloblastoma", "Refractory Brain Neoplasm", "Refractory Diffuse Intrinsic Pontine Glioma", "Refractory Ependymoma", "Refractory Medulloblastoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 110,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03322592",
          "briefTitle": "EUS-FNB With ROSE Vs. EUS-FNB Without ROSE"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Biopsy, Fine-needle", "Pancreatic Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 800,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02068729",
          "briefTitle": "Comparison of Complication Rates Between Lateral Approaches to the Lumbar Spine"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-06"
          },
          "completionDateStruct": {
            "date": "2020-02-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Degenerative Disc Disease", "Grade 1 Spondylolisthesis"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 131,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00684645",
          "briefTitle": "Non-Interventional Study (NIS) In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT®"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-06"
          },
          "completionDateStruct": {
            "date": "2011-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Renal Cell Carcinoma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 186,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02294357",
          "briefTitle": "Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12"
          },
          "completionDateStruct": {
            "date": "2020-09-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01107639",
          "briefTitle": "Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-05-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-12-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Adenocarcinoma of the Gastroesophageal Junction", "Esophageal Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 297,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03310957",
          "briefTitle": "Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-02-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Triple Negative Breast Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 185,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04360330",
          "briefTitle": "SABER Study for Selected Early Stage Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Breast Cancer", "Early-stage Breast Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06851767",
          "briefTitle": "Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2034-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["X-linked Severe Combined Immunodeficiency", "X-SCID", "XSCID"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "3 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01496807",
          "briefTitle": "Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-02-17"
          },
          "completionDateStruct": {
            "date": "2016-08-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 31,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04735471",
          "briefTitle": "A Phase 1 Study of ADI-001 in B Cell Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-02-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoma, Follicular", "Lymphoma, Mantle-Cell", "Marginal Zone Lymphoma", "Primary Mediastinal B-cell Lymphoma", "Diffuse Large B Cell Lymphoma", "Lymphoma, Non-Hodgkin"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02290301",
          "briefTitle": "An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-06-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-11-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Type 2 Diabetes Mellitus"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 5180,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05081219",
          "briefTitle": "SNIFF - Combo INI+EMPA Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Mild Cognitive Impairment", "Cognitive Impairment", "Alzheimer Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 47,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "55 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06017765",
          "briefTitle": "Coping After Loss Through Mindfulness in Adults With Prolonged Grief Disorder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Prolonged Grief Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05663892",
          "briefTitle": "Drug-Drug Interaction Study in Trans Women Living With HIV"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hiv", "Transgenderism"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06267664",
          "briefTitle": "Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Migraine", "Migraine Disorders", "Migraine With Aura", "Headache Disorders"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06931132",
          "briefTitle": "Cancer-related Fatigue and Symptom Clusters - Effects of Virtual, Imagined and Real-life Nature-based Therapy in Cancer Survivors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cancer Survivors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 172,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01393132",
          "briefTitle": "Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-03"
          },
          "completionDateStruct": {
            "date": "2012-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Dry Eye", "Sjogren's Syndrome", "Graft vs. Host Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02014441",
          "briefTitle": "Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-04-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-04-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 61,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02340156",
          "briefTitle": "Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12"
          },
          "completionDateStruct": {
            "date": "2018-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "RECURRENT GLIOBLASTOMA"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00461045",
          "briefTitle": "Phase 2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-03"
          },
          "completionDateStruct": {
            "date": "2014-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03203473",
          "briefTitle": "Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Renal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 85,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02502266",
          "briefTitle": "Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07-16",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Fallopian Tube Clear Cell Adenocarcinoma", "Fallopian Tube Endometrioid Adenocarcinoma", "Fallopian Tube Serous Adenocarcinoma", "Fallopian Tube Transitional Cell Carcinoma", "Fallopian Tube Undifferentiated Carcinoma", "Ovarian Clear Cell Adenocarcinoma", "Ovarian Endometrioid Adenocarcinoma", "Ovarian Seromucinous Carcinoma", "Ovarian Serous Adenocarcinoma", "Ovarian Transitional Cell Carcinoma", "Ovarian Undifferentiated Carcinoma", "Primary Peritoneal Serous Adenocarcinoma", "Recurrent Fallopian Tube Carcinoma", "Recurrent Ovarian Carcinoma", "Recurrent Primary Peritoneal Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 582,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06185751",
          "briefTitle": "Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2040-08-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02352051",
          "briefTitle": "Effects of Atx and Oros-mph on Executive Functions"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-02"
          },
          "completionDateStruct": {
            "date": "2014-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Executive Dysfunction"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 43,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "7 Years",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06180837",
          "briefTitle": "Effect of Sleep Extension on Ceramides in People with Overweight and Obesity"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-02-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Lifestyle Factors", "Overweight and Obesity", "Insulin Sensitivity", "Eating Habit", "Sleep Hygiene", "Type 2 Diabetes", "Sleep", "Sleep Deprivation", "Insufficient Sleep Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06826677",
          "briefTitle": "REAL-WORLD DURVALUMAB IN EXTENSIVE-STAGE SMALL CELL LUNG CANCER"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Small Cell Lung Carcinoma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 71,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04889157",
          "briefTitle": "A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of PF-06882961 in Chinese Adults With Type 2 Diabetes Mellitus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes Mellitus, Type 2"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03696901",
          "briefTitle": "Xydalba Utilization Registry in Germany"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-04-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Bacterial Infections"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05617456",
          "briefTitle": "Advanced TecHnologies For SuccEssful AblatioN of AF in Clinical Practice"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cardiac Arrhythmia", "Atrial Fibrillation"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 4100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03087929",
          "briefTitle": "Follow-up Trial of Rituximab Interferon Transplant Trial: Study Drug-Rituximab and Alpha Interferon"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-09-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-03-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Follicular"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07060729",
          "briefTitle": "Exploring How Exercise Frequency Impacts Muscle Resistance and Balance in Institutionalized Seniors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01-02",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-06-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Frequency of Treatment Protocol"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "65 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02256137",
          "briefTitle": "A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-10-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Brain Tumor", "Hodgkin Lymphoma"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1564,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02366195",
          "briefTitle": "Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-04-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Unresected Stage IIIb to IVM1c Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 112,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04444895",
          "briefTitle": "A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Angioedema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 73,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05556239",
          "briefTitle": "STAY-STRONG Study of Exercise Training During Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-10-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-05-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoma, B-Cell", "Lymphoma, Hodgkin", "Exercise", "Body Composition", "Physical Functional Performance", "Quality of Life", "Sarcopenia", "Muscle, Skeletal", "Patient Reported Outcome Measures"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05817812",
          "briefTitle": "A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog Alfa"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-07-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hemophilia A, Severe"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 93,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03217812",
          "briefTitle": "A Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-Dose Therapy (Asia Pacific Region)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-11-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 220,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01068730",
          "briefTitle": "Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-02"
          },
          "completionDateStruct": {
            "date": "2010-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Type 2 Diabetes Mellitus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06832865",
          "briefTitle": "ELISA in Relapsed/Refractory MM"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-08-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Relapsed Refractory Multiple Myeloma (RRMM)", "Relapsed Refractory Multiple Myeloma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01654965",
          "briefTitle": "Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-07-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-03-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Adult Solid Neoplasm"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01251367",
          "briefTitle": "Dysport® Adult Lower Limb Spasticity Follow-on Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-06"
          },
          "completionDateStruct": {
            "date": "2015-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Post-stroke Spasticity", "Spasticity Post-Traumatic Brain Injury"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 352,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02488759",
          "briefTitle": "An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-10-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Various Advanced Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 578,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06192979",
          "briefTitle": "Optimize First-line Treatment for AL Amyloidosis With t (11; 14)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Amyloidosis; Systemic", "AL Amyloidosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 41,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02127762",
          "briefTitle": "The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-09"
          },
          "completionDateStruct": {
            "date": "2016-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetes Mellitus", "Type I Diabetes", "Type II Diabetes", "Diabetic Peripheral Neuropathy", "Chronic Pain"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 81,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03919162",
          "briefTitle": "A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Alzheimer Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 112,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "89 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06376786",
          "briefTitle": "Italian iTTP Registry"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-06-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-05-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "TTP - Thrombotic Thrombocytopenic Purpura"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 132,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05902169",
          "briefTitle": "Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Glioblastoma", "Recurrent Glioblastoma", "GBM"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 560,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03816683",
          "briefTitle": "A Disease Registry of Patients With Mantle Cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Mantle Cell Lymphoma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 227,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "130 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05057494",
          "briefTitle": "A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-04-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 607,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "130 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06692556",
          "briefTitle": "Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carcinomas Spinocellular With High Risk of Recurrence"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cutaneous Squamous Cell Carcinoma (CSCC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 266,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01399372",
          "briefTitle": "Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-09"
          },
          "completionDateStruct": {
            "date": "2022-05-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chemotherapeutic Agent Toxicity", "Cognitive/Functional Effects", "Lymphoma", "Neurotoxicity", "Radiation Toxicity"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 91,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03397173",
          "briefTitle": "TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-01-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Myelodysplastic Syndromes", "Myeloproliferative Neoplasm", "Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07179783",
          "briefTitle": "Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-22",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostate Cancer (Adenocarcinoma)", "Prostate Cancer Metastatic Castration-Resistant", "Prostate Adenocarcinoma With Neuroendocrine Differentiation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02987686",
          "briefTitle": "Topical Infliximab for Sterile Corneal Melt"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-09-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Sterile Corneal Melt"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01556594",
          "briefTitle": "Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-03"
          },
          "completionDateStruct": {
            "date": "2012-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hypoglycemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06007651",
          "briefTitle": "A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-02-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Dyslipidemias", "Non-Alcoholic Fatty Liver Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 49,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07028853",
          "briefTitle": "This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2034-12-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Metastatic Castration Sensitive Prostate Cancer (mCSPC)", "Hormone Sensitive Prostate Cancer", "Prostate Cancer", "Cancer of the Prostate"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05181501",
          "briefTitle": "A Study of Fully Human BCMA CAR-T (CT103A) in Patients With Newly Diagnosed High-risk Multiple Myeloma (FUMANBA-2)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-04",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2039-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04599751",
          "briefTitle": "The Trio Laser Module for Hair Removal Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hair Removal Treatment"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 37,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04123951",
          "briefTitle": "Home-based Exercise in Renal Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Transplant; Complications"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04762602",
          "briefTitle": "A Study of HMPL-306 in Advanced Solid Tumors With IDH Mutations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-02-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Isocitrate Dehydrogenase Gene Mutation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02621502",
          "briefTitle": "Quinoa Effects on Glycemic Index and Satiety"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-09"
          },
          "completionDateStruct": {
            "date": "2015-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Overweight"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 8,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00206102",
          "briefTitle": "A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-09"
          },
          "completionDateStruct": {
            "date": "2008-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Schizophrenia", "Schizoaffective Disorder"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1098,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03665545",
          "briefTitle": "Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Glioblastoma Multiforme", "Glioblastoma, Adult", "Glioma of Brain", "Glioblastoma Multiforme of Brain"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06564545",
          "briefTitle": "A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Lymphoblastic Leukemia, Adult"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 276,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06849401",
          "briefTitle": "The Safety and Efficacy of VGO-Cs01p in Patients With CD7-positive Relapsed/Refractory Acute T-lymphoblastic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "T-ALL"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03809286",
          "briefTitle": "The Effect of rTMS to the Prefrontal Cortex in Alcohol Use Disorder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Alcohol Use Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "22 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06387069",
          "briefTitle": "A Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 316,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04669522",
          "briefTitle": "Psychological Factors and Oncological Outcomes of Triple-negative Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2021-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Triple Negative Breast Neoplasms"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      }
    ],
    "protocolSection.2": [
      {
        "identificationModule": {
          "nctId": "NCT05629702",
          "briefTitle": "ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Glioblastoma", "Brain Tumor", "Cannabis", "Brain Tumor, Recurrent"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06794645",
          "briefTitle": "Pembrolizumab and Pemetrexed for Progressive Chordoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chordomas", "Chordoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07142057",
          "briefTitle": "An Observational Study on the Impact of the 23-valent Pneumonia Vaccine on Lung Cancer Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2030-09-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "LUNG CANCER"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05605301",
          "briefTitle": "Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Epilepsy; Seizure"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03207867",
          "briefTitle": "A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-08-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["NSCLC, Non Small Cell Lung Cancer", "RCC, Renal Cell Cancer", "Pancreatic Cancer", "Urothelial Cancer", "Head and Neck Cancer", "DLBCL, Diffused Large B Cell Lymphoma", "MSS, Microsatellite Stable Colon Cancer", "TNBC, Triple Negative Breast Cancer", "Melanoma", "mCRPC, Metastatic Castration Resistant Prostate Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 315,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03323151",
          "briefTitle": "A Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-08-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Mantle-Cell Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 43,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06863922",
          "briefTitle": "A Pilot Study of Berberine (Soloways ™) in Patients with Type 2 Diabetes Mellitus Carrying TCF7L2 Polymorphisms"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-10-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes Mellitus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "30 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03579602",
          "briefTitle": "Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pediatric Central Nervous System Tumor"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 118,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Month",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06087653",
          "briefTitle": "Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04927702",
          "briefTitle": "Assessment of Wound Closure Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers (DFU) and With Living Cellular Skin Substitute in Treating Venous Leg Ulcers (VLU)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetic Foot Ulcer", "Venous Leg Ulcer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 47,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06897202",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Obesity in Diabetes", "Type 2 Diabetes Mellitus (T2DM)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 133,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05849337",
          "briefTitle": "The Lóa Study: a Brief Digital Intervention for Women with Intrusive Memories in the SAGA Cohort"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Intrusive Memories of Traumatic Event(s)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 380,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "73 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05420545",
          "briefTitle": "A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Metastatic Tumor", "Advanced Solid Tumor", "Renal Cell Carcinoma", "Ovarian Cancer", "Cervix Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03859739",
          "briefTitle": "Safety, Tolerability, Pharmacokinetics, and Anti-Retroviral Activity of MK-8558 Monotherapy in Anti-Retroviral-Naïve HIV-1 Infected Participants (MK-8558-002)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-04-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-05-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV-1 Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01124812",
          "briefTitle": "131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-05"
          },
          "completionDateStruct": {
            "date": "2012-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non Small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02803905",
          "briefTitle": "Islet Transplant Alone in OMENtum"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-04"
          },
          "completionDateStruct": {
            "date": "2024-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Islets of Langerhans Transplantation", "Diabetes Mellitus, Type 1"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07267494",
          "briefTitle": "Image-Guided Herniorrhaphy Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-01-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hernia", "Hernia Abdominal Wall", "Ventral Hernia", "Inguinal Hernia", "Hiatal Hernia", "Diastasis Recti"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04773951",
          "briefTitle": "A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-04-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Melanoma", "Renal Carcinoma", "Urothelial Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 156,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06462001",
          "briefTitle": "BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Transitional Cell Carcinoma", "Transurethral Resection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 500,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00810030",
          "briefTitle": "FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-10"
          },
          "completionDateStruct": {
            "date": "2010-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Inflammatory Bowel Disease", "Anemia", "Iron Deficiency", "Iron-Deficiency Anemia", "Crohn's Disease", "Ulcerative Colitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 484,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02656628",
          "briefTitle": "Observational Patient Registry of the Dynamic Locking Screws"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-05"
          },
          "completionDateStruct": {
            "date": "2016-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Proximal or Diaphyseal Humerus Fracture", "Diaphyseal or Distal Femur Fracture", "Diaphyseal, Distal or Proximal Tibia Fracture"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01808820",
          "briefTitle": "Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-08-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-07-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Malignant Glioma", "Glioblastoma Multiforme", "Anaplastic Astrocytoma", "High Grade Glioma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "13 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05041062",
          "briefTitle": "A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Mesothelioma", "Peritoneal Mesothelioma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03255096",
          "briefTitle": "A Study to Evaluate Safety, Pharmacokinetics, and Clinical Activity of Combination of RO6870810 and Venetoclax, With or Without Rituximab, in Participants With Relapsed/Refractory DLBCL and/or High-Grade B-Cell Lymphoma and/or High Grade B-Cell Lymphoma With MYC and/or BCL2 and/or BCL6"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-08-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-07-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diffuse Large B-cell Lymphoma", "High-Grade B-cell Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 39,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06187961",
          "briefTitle": "Combined HAIC, Lenvatinib and Cadonilimab As Conversion Therapy for Unresectable Hepatocellular Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatocellular Carcinoma Non-resectable"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03031483",
          "briefTitle": "Clarithromycin + Lenalidomide Combination: a Full Oral Treatment for Patients With Relapsed/Refractory Extranodal Marginal Zone Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-04-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Mucosa Associated Lymphoid Tissue (MALT) Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05266768",
          "briefTitle": "Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of IBI346#CIBI346Y002#"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-04-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Relapsed/Refractory Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02145468",
          "briefTitle": "A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-06-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-12-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Coronary Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3503,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "35 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05113290",
          "briefTitle": "Effect and Safety of Recombinant Human Adenovirus Type 5 in Advanced HCC With Stable Disease After Sorafenib Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatocellular Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 66,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06192797",
          "briefTitle": "Combined HAIC, Lenvatinib and Pucotenlimab As Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-06-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cholangiocarcinoma Non-resectable"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04827810",
          "briefTitle": "A Phase I Safety and Pharmacokinetic Study of Gamitrinib Administered Intravenously to Patients With Advanced Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoma", "Advanced Solid Tumor"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06815003",
          "briefTitle": "Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-10-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "Chronic Myelomonocytic Leukemia", "Graft Versus Host Disease", "Myelodysplastic Syndrome", "Myeloproliferative Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05116683",
          "briefTitle": "ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leiomyosarcoma", "Liposarcoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04037254",
          "briefTitle": "Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-10-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-09-26",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostate Adenocarcinoma", "Stage IIC Prostate Cancer AJCC v8", "Stage III Prostate Cancer AJCC v8", "Stage IIIA Prostate Cancer AJCC v8", "Stage IIIB Prostate Cancer AJCC v8", "Stage IIIC Prostate Cancer AJCC v8", "Stage IVA Prostate Cancer AJCC v8"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 22,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07211308",
          "briefTitle": "Open and Closed Loop DTM SCS in Patients With PSPS Type 2: ENDLESS Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-01-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Persistent Spinal Pain Syndrome Type 2", "Failed Back Surgery Syndrome", "Failed Neck Surgery Syndrome"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04463108",
          "briefTitle": "A Study to Describe Routine Treatment Pathways in Participants With Major Depression and Active Suicidal Ideation With Intent in Italy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Depressive Disorder, Major", "Suicidal Ideation"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 136,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "74 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03507491",
          "briefTitle": "Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-08-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03014674",
          "briefTitle": "A Study to Compare the Pharmacokinetics of Mepolizumab as a Liquid Drug in a Safety Syringe or an Autoinjector Versus Lyophilised Drug"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-08-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 246,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05892718",
          "briefTitle": "A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-11-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Solid Tumor", "Refractory Non-Hodgkin Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04676997",
          "briefTitle": "Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Triple Negative Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03825146",
          "briefTitle": "The Effects of AMPC in the Treatments of Refractory or Relapsed AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukaemia Recurrent"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01890746",
          "briefTitle": "A Safety and Efficacy Study of Eltrombopag in Subjects With AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-09-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-01-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Leukaemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 148,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01501370",
          "briefTitle": "Vorinostat Plus Lenalidomide and Dexamethasone or Lenalidomide Plus Dexamethasone in Multiple Myeloma Patients Who Experience Biochemical Relapse During Lenalidomide Maintenance Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-01"
          },
          "completionDateStruct": {
            "date": "2012-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02822586",
          "briefTitle": "TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-12-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-04-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Mycosis Fungoides", "Sézary Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03908125",
          "briefTitle": "Post Approval Study of the Eversense® Continuous Glucose Monitoring"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetes Mellitus", "Diabetes Mellitus, Type 1", "Diabetes Mellitus, Type 2"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 273,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00107718",
          "briefTitle": "Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-11-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2006-05-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 64,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03049618",
          "briefTitle": "Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["ALK Gene Mutation", "BRAF Gene Mutation", "EGFR Gene Mutation", "Head and Neck Squamous Cell Carcinoma", "Metastatic Head and Neck Carcinoma", "Recurrent Head and Neck Carcinoma", "Recurrent Non-Small Cell Lung Carcinoma", "ROS1 Gene Mutation", "Stage III Non-Small Cell Lung Cancer", "Stage IIIA Non-Small Cell Lung Cancer", "Stage IIIB Non-Small Cell Lung Cancer", "Stage IV Non-Small Cell Lung Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02569320",
          "briefTitle": "HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-03-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Recurrent Plasma Cell Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02679196",
          "briefTitle": "The Safety, Pharmacokinetic and Pharmacodynamic Effect of KA2237 (PI3 Kinase p110β/δ Inhibitor) In B Cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-07"
          },
          "completionDateStruct": {
            "date": "2018-12-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, B Cell"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04958473",
          "briefTitle": "A Study of Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-08-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Renal Cell Carcinoma", "Clear Cell Renal Cell Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05036473",
          "briefTitle": "A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-10-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-16",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Parkinson Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "30 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07132918",
          "briefTitle": "HEARTS Trial for Thoracic Cancers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Non-Small Cell Lung Cancer (Stage III)", "Esophageal Cancer Stage I-III", "Esophagogastric Cancer Stage I-III", "Thymoma and Thymic Carcinoma Stage II-III", "Other Cancers in the Thoracic Region"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04056520",
          "briefTitle": "Clinical and Radiological Outcomes of Posterior Cervical Fusion with Medtronic Infinity Occipitocervical-Upper Thoracic (OCT) System"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Degenerative Disc Disease"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 54,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06302582",
          "briefTitle": "Platelet Rich Plasma Combined With Human Umbilical Cord Mesenchymal Stem Cells for Stage 3 and 4 Stress Injury"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-02-29",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-11-25",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Pressure Injuries - Stage 3", "Pressure Injuries - Stage 4"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02408861",
          "briefTitle": "Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-10-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Malignant Solid Neoplasm", "Anal Carcinoma", "HIV Infection", "Kaposi Sarcoma", "Lung Carcinoma", "Metastatic Malignant Solid Neoplasm", "Recurrent Classic Hodgkin Lymphoma", "Refractory Classic Hodgkin Lymphoma", "Unresectable Solid Neoplasm", "HIV-associated Cancers"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 79,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05618470",
          "briefTitle": "Wumeiwan Jiawei Fang Use in Patients With Blepharospasm"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Dry Eye Syndromes", "Meige Syndrome", "Blepharospasm", "Hyperactivity"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05785208",
          "briefTitle": "Efficacy Study of Osimertinib in Treatment-naïve Patients With EGFR Mutant NSCLC According to TP53 Mutational Status."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Non Small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 122,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04534725",
          "briefTitle": "COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Cancer", "Covid19", "Respiratory Viral Infection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 441,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02639117",
          "briefTitle": "Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-11-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-11-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Basal Cell Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02719574",
          "briefTitle": "Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-04-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Acute Myelogenous Leukemia", "Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 336,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06745024",
          "briefTitle": "Comparing Radiation Therapy to Usual Care for Patients With High-Risk Bone Asymptomatic Metastases, PREEMPT Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-02-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Metastatic Malignant Neoplasm in the Bone", "Metastatic Malignant Solid Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 280,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02126579",
          "briefTitle": "Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-05-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Melanoma", "Metastatic Melanoma", "Mucosal Melanoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06537427",
          "briefTitle": "The Crosstalk Between the Epigenome and Mitochondria in SCI"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08-30",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-08-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Injury, Spinal Cord"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06236386",
          "briefTitle": "Virtual Reality During Colonoscopy Procedures"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-02-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Colorectal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01621490",
          "briefTitle": "PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-09-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-10-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Melanoma", "Metastatic Melanoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 170,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05057013",
          "briefTitle": "A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Bladder Cancer", "Triple Negative Breast Cancer", "Castration-resistant Prostate Cancer", "Cervical Cancer", "RAS Wild Type Colorectal Cancer", "Endometrial Cancer", "Gastric Cancer", "Hepatocellular Carcinoma (HCC)", "Melanoma", "Non-small Cell Lung Cancer (NSCLC)", "Oesophageal Cancer", "Ovarian Cancer", "Pancreatic Cancer", "Squamous Cell Cancer of the Head and Neck"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 81,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06218420",
          "briefTitle": "Evaluation of Stereotactic Body Radiotherapy as a Bridge Therapy for Hepatocellular Carcinoma Patients Enlisted for Liver Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatocellular Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 139,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01519323",
          "briefTitle": "BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-01"
          },
          "completionDateStruct": {
            "date": "2015-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Malignant Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04237623",
          "briefTitle": "GM-CSF With Post-Transplant Cyclophosphamide"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-09-18",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Transplant-Related Hematologic Malignancy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "78 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05451862",
          "briefTitle": "Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-05-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatocellular Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05171062",
          "briefTitle": "Dose Escalation Trial of Bexmarilimab (FP-1305) Plus Pembrolizumab in Non-Small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Non-small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00566696",
          "briefTitle": "Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-12-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-02-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia, Acute Lymphocytic (ALL)", "Leukemia, Myeloid, Acute(AML)", "Leukemia, Myeloid, Chronic(CML)", "Juvenile Myelomonocytic Leukemia (JMML)", "Hemoglobinuria, Paroxysmal Nocturnal (PNH)", "Hodgkin Lymphoma", "Lymphoma, Non-Hodgkin (NHL)", "Myelodysplastic Syndrome (MDS)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 73,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07230288",
          "briefTitle": "Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-02-11",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Pulmonary Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 165,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07234903",
          "briefTitle": "ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2032-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Spinal Cord Injury", "SCI", "SCI - Spinal Cord Injury", "Subacute Spinal Cord Injury", "Chronic Spinal Cord Injury", "Spinal Cord Injury (SCI)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03250676",
          "briefTitle": "Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-08-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Breast Neoplasms", "Breast Cancer", "Estrogen-receptor Positive Breast Cancer", "Cancer, Breast", "Breast Cancer Female", "Breast Adenocarcinoma", "Estrogen Receptor Positive Tumor", "ER Positive"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 151,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06484491",
          "briefTitle": "IMPT Dose Escalation for NSCLC (HyDose)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Non-Small-Cell Lung"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 87,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02228174",
          "briefTitle": "Sonography Guided Transcervical Ablation of Uterine Fibroids"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-10"
          },
          "completionDateStruct": {
            "date": "2019-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Menorrhagia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 147,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "25 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06187597",
          "briefTitle": "Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Locally Advanced Esophageal Squamous Cell Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 140,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "70 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03289910",
          "briefTitle": "Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-09-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-19",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome", "Atypical Chronic Myeloid Leukemia", "Chronic Myelomonocytic Leukemia", "Essential Thrombocythemia", "Myelodysplastic/Myeloproliferative Neoplasm", "Myelofibrosis", "Polycythemia Vera", "Recurrent Acute Myeloid Leukemia", "Refractory Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01421927",
          "briefTitle": "Lenalidomide After Reduced-intensity Allogeneic Stem Cell Transplantation for Relapsed Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-08"
          },
          "completionDateStruct": {
            "date": "2014-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 13,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01449461",
          "briefTitle": "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-Tumor Activity of the Oral Anaplastic Lymphoma Kinase (ALK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Brigatinib (AP26113)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-09-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-02-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoma, Large-Cell, Anaplastic", "Carcinoma, Non-Small-Cell Lung"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 137,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05539625",
          "briefTitle": "Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02709408",
          "briefTitle": "European Prospective Cohort Study on Enterobacteriaceae Showing Resistance to Carbapenems"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-04-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-12-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Carbapenem Resistant Bacteria Infection"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 2515,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02432040",
          "briefTitle": "Efficacy of Atorvastatin as Adjunctive Treatment for Chronic Plaque Type Psoriasis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-02"
          },
          "completionDateStruct": {
            "date": "2013-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Psoriasis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02332668",
          "briefTitle": "A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-10-25",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Melanoma", "Lymphoma", "Solid Tumor", "Classical Hodgkin Lymphoma", "Microsatellite-instability-high Solid Tumor"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 370,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03348891",
          "briefTitle": "TNF in Melanoma Patients Treated With Immunotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-09-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01967888",
          "briefTitle": "Efficacy and Safety of Reparixin in Pancreatic Islet Auto-transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pancreatectomy for Chronic Pancreatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 104,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05136196",
          "briefTitle": "BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-01-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Clinical Stage III Cutaneous Melanoma AJCC v8", "Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "Clinical Stage IV Cutaneous Melanoma AJCC v8", "Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "Locally Recurrent Head and Neck Squamous Cell Carcinoma", "Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma", "Locally Recurrent Laryngeal Squamous Cell Carcinoma", "Locally Recurrent Oral Cavity Squamous Cell Carcinoma", "Locally Recurrent Oropharyngeal Squamous Cell Carcinoma", "Metastatic Head and Neck Squamous Cell Carcinoma", "Metastatic Hypopharyngeal Squamous Cell Carcinoma", "Metastatic Laryngeal Squamous Cell Carcinoma", "Metastatic Melanoma", "Metastatic Oral Cavity Squamous Cell Carcinoma", "Metastatic Oropharyngeal Squamous Cell Carcinoma", "Recurrent Melanoma", "Stage III Hypopharyngeal Carcinoma AJCC v8", "Stage III Laryngeal Cancer AJCC v8", "Stage III Lip and Oral Cavity Cancer AJCC v8", "Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage IV Hypopharyngeal Carcinoma AJCC v8", "Stage IV Laryngeal Cancer AJCC v8", "Stage IV Lip and Oral Cavity Cancer AJCC v8", "Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Unresectable Melanoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06936488",
          "briefTitle": "A Prospective, Single Arm, Open Label, Phase II Clinical Study on the Efficacy and Safety of Ivonescimab (AK112) Combined With TAS-102 in the Treatment of Refractory MSS/pMMR Advanced Colorectal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "MSS/pMMR Type Metastatic Colorectal Adenocarcinoma Patients"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03454503",
          "briefTitle": "Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-05-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 173,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07226986",
          "briefTitle": "A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-16",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-08-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 123,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05917405",
          "briefTitle": "Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-09-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-09-14",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia in Remission"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 302,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00528866",
          "briefTitle": "Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01555762",
          "briefTitle": "An Observational Study of Avastin in First Line in Elderly Patients With Metastatic Colorectal Cancer (CASSIOPEE)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-03-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-07-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Colorectal Cancer"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 402,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01975662",
          "briefTitle": "Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01"
          },
          "completionDateStruct": {
            "date": "2015-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Bacteremia Due to Staphylococcus Aureus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02106442",
          "briefTitle": "36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg Tablets"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-05-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-04-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Osteoporosis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 579,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03346070",
          "briefTitle": "Efficacy and Safety of Sugammadex Dosed According to Actual Body Weight (ABW) or Ideal Body Weight (IBW) in Reversal of Neuromuscular Blockade (NMB) in Morbidly Obese Participants (MK-8616-146)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-01-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neuromuscular Blockade"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 207,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06114173",
          "briefTitle": "Efficacy and Safety Study of Cardunilizumab in Soft Tissue Sarcoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Sarcoma, Soft Tissue"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04350554",
          "briefTitle": "Pregnancy in Women With HIV Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2021-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["HIV Infections", "Pregnancy Related"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 160,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03161756",
          "briefTitle": "Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-12-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Melanoma Stage Iv", "Melanoma Stage Iii", "Melanoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 72,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      }
    ]
  }
}
